Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3

Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3–deficient mice

Published:2009-02 Issue:2 Volume:137 Page:471-480.e2
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Angoulvant Denis,Fazel Shafie,Weisel Richard D.,Lai Teresa Y.Y.,Fedak Paul W.,Chen Liwen,Rafati Shahin,Seneviratne Charit K.,Degousee Norbert,Li Ren-Ke

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference34 articles.

1. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines;Fazel;J Clin Invest,2006

2. Effects of cell-based angiogenic gene therapy at 6 months: persistent angiogenesis and absence of oncogenicity;Kim;Ann Thorac Surg,2007

3. Enhanced angiogenesis with multimodal cell-based gene therapy;Yau;Ann Thorac Surg,2007

4. Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism;Fedak;J Thorac Cardiovasc Surg,2005

5. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat;Peterson;Cardiovasc Res,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and Its Therapeutic Implications in Cardiovascular Pathology;Frontiers in Physiology;2020-06-16

2. Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events;Archives of Cardiovascular Diseases;2017-12

3. An appropriate loading control for western blot analysis in animal models of myocardial ischemic infarction;Biochemistry and Biophysics Reports;2017-12

4. Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?;Transfusion Medicine and Hemotherapy;2016

5. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction;Transplant Immunology;2014-05